These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 31832521)
41. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma]. Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731 [No Abstract] [Full Text] [Related]
42. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11. Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064 [TBL] [Abstract][Full Text] [Related]
43. Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal Prukova D; Andera L; Nahacka Z; Karolova J; Svaton M; Klanova M; Havranek O; Soukup J; Svobodova K; Zemanova Z; Tuskova D; Pokorna E; Helman K; Forsterova K; Pacheco-Blanco M; Vockova P; Berkova A; Fronkova E; Trneny M; Klener P Clin Cancer Res; 2019 Jul; 25(14):4455-4465. PubMed ID: 31004002 [TBL] [Abstract][Full Text] [Related]
45. [Effect of Carfilzomib on Proliferation and Apoptosis of Mantle Cell Lymphoma Cells]. Jiang GX; Li DY; Chen M; Liu YC; Chen JX; Shi XF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):827-832. PubMed ID: 31204939 [TBL] [Abstract][Full Text] [Related]
46. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib. Zhao LL; Liu YF; Peng LJ; Fei AM; Cui W; Miao SC; Hermine O; Gressin R; Khochbin S; Chen SJ; Wang J; Mi JQ Cancer Med; 2015 Nov; 4(11):1754-66. PubMed ID: 26310857 [TBL] [Abstract][Full Text] [Related]
47. Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma. Stein L; Bacmeister C; Ylaya K; Fetsch P; Wang Z; Hewitt SM; Kiupel M Vet Pathol; 2019 May; 56(3):350-357. PubMed ID: 30636524 [TBL] [Abstract][Full Text] [Related]
48. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012 [TBL] [Abstract][Full Text] [Related]
49. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
50. FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma. Liu Q; Alinari L; Chen CS; Yan F; Dalton JT; Lapalombella R; Zhang X; Mani R; Lin T; Byrd JC; Baiocchi RA; Muthusamy N Clin Cancer Res; 2010 Jun; 16(12):3182-92. PubMed ID: 20460491 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. Yang DT; Young KH; Kahl BS; Markovina S; Miyamoto S Mol Cancer; 2008 May; 7():40. PubMed ID: 18489772 [TBL] [Abstract][Full Text] [Related]
52. Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop. Williams ME; Connors JM; Dreyling MH; Gascoyne RD; Kahl BS; Leonard JP; Press OW; Wilson WH Leuk Lymphoma; 2011 Jan; 52(1):24-33. PubMed ID: 21133727 [TBL] [Abstract][Full Text] [Related]
53. Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease. Pham LV; Vang MT; Tamayo AT; Lu G; Challagundla P; Jorgensen JL; Rollo AA; Ou Z; Zhang L; Wang M; Ford RJ Leuk Lymphoma; 2015 Jan; 56(1):186-93. PubMed ID: 24611650 [TBL] [Abstract][Full Text] [Related]
54. The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma. Hanf M; Chiron D; de Visme S; Touzeau C; Maisonneuve H; Jardel H; Pellat-Deceunynck C; Amiot M; le Gouill S BMC Cancer; 2016 Oct; 16(1):802. PubMed ID: 27737650 [TBL] [Abstract][Full Text] [Related]
55. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL). Asaad NY; Abd El-Wahed MM; Dawoud MM J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815 [TBL] [Abstract][Full Text] [Related]
56. Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop. Kahl BS; Dreyling M; Gordon LI; Martin P; Quintanilla-Martinez L; Sotomayor EM Leuk Lymphoma; 2019 Aug; 60(8):1853-1865. PubMed ID: 30696305 [TBL] [Abstract][Full Text] [Related]
57. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733 [TBL] [Abstract][Full Text] [Related]
58. Smoldering mantle cell lymphoma. Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179 [TBL] [Abstract][Full Text] [Related]
59. An Aggressive Presentation of Mantle Cell Lymphoma With Unique Molecular Features. Inamdar AA; Loo A; Mikhail N; Lee P Cureus; 2021 Aug; 13(8):e17598. PubMed ID: 34646650 [TBL] [Abstract][Full Text] [Related]